Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test

Charlotte E Teunissen; Elisabeth H Thijssen; Inge M W Verberk

doi:10.1093/brain/awaa329

Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test

Brain. 2020 Dec 5;143(11):3170-3172. doi: 10.1093/brain/awaa329.

Authors

Charlotte E Teunissen¹, Elisabeth H Thijssen¹, Inge M W Verberk¹

Affiliation

¹ Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Abstract

This scientific commentary refers to ‘Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease’, by Mattsson-Carlgren et al. (doi:10.1093/brain/awaa286).

Publication types

Comment

MeSH terms

Alzheimer Disease* / drug therapy
Hematologic Tests
Humans
Plasma